Evidence map›Paper›PMID 34373677›Full record

ArticleMediators of inflammation2021

Identification of the Molecular Basis of Nanocurcumin-Induced Telocyte Preservation within the Colon of Ulcerative Colitis Rat Model.

Eetmad A Arafat, Rehab Elsayed Marzouk, Sally Abdallah Mostafa, Walaa H E Hamed

Abstract read
In one paragraph

Article in Mediators of inflammation, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Role of CD34 in inflammatory bowel disease.Frontiers in physiology · 2023
    Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Eetmad A ArafatHistology and Cell Biology Department, Faculty of Medicine, Mansoura University, Mansoura 35511, Egypt.ORCID https://orcid.org/0000-0002-4984-3266
Rehab Elsayed MarzoukMedical Biochemistry and Molecular Biology Department, Faculty of Medicine, Mansoura University, Mansoura 35511, Egypt.ORCID https://orcid.org/0000-0002-5551-1540
Sally Abdallah MostafaMedical Biochemistry and Molecular Biology Department, Faculty of Medicine, Mansoura University, Mansoura 35511, Egypt.ORCID https://orcid.org/0000-0002-5880-8630
Walaa H E HamedHistology and Cell Biology Department, Faculty of Medicine, Mansoura University, Mansoura 35511, Egypt.ORCID https://orcid.org/0000-0001-9913-8648

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTelocytes (TCs) are a distinct type of interstitial cells that play a vital role in the pathogenesis of ulcerative colitis and colonic tissue hemostasis. The aim of this study was to examine the effect of nanocurcumin (NC) on the morphometric and immunohistochemical characterization of TCs in the ulcerative colitis (UC) rat model.

methodsForty rats were randomly divided into control, NC, UC, and UC+NC groups. At the end of the experiment, the colon was dissected and prepared for histopathological and immunohistochemical assessment. Tissue homogenates were prepared for real-time PCR assessment of interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-

conclusionNC successfully targeted the colonic tissue, improved the mucosal lesion, preserve TCs distribution, and count through its anti-inflammatory and fibrinolytic properties.

Indexed as

AnimalsColitisColitis, UlcerativeColonCurcuminDisease Models, AnimalFibrinolysisGene Expression RegulationImmunohistochemistryInflammationInterleukin-6Intestinal MucosaMaleNanoparticlesRatsRats, WistarCurcuminIl6 protein, ratInterleukin-6Tgfb1 protein, ratTransforming Growth Factor beta1Tumor Necrosis Factor-alphaVimentin

Identifiers

PMID34373677
PMCPMC8349286

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.